Home/Filings/4/0001809519-25-000146
4//SEC Filing

Nabiey Romin 4

Accession 0001809519-25-000146

CIK 0001809519other

Filed

Nov 9, 7:00 PM ET

Accepted

Nov 10, 5:14 PM ET

Size

8.3 KB

Accession

0001809519-25-000146

Insider Transaction Report

Form 4
Period: 2025-11-08
Nabiey Romin
Chief Accounting Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Unit

    2025-11-0812,66275,977 total
    Class A Common Stock (12,662 underlying)
  • Exercise/Conversion

    Class A Common Stock

    2025-11-08+12,662157,938 total
  • Tax Payment

    Class A Common Stock

    2025-11-08$3.11/sh4,531$14,091153,407 total
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
  • [F2]The restricted stock units vest as to 6.25% of the underlying shares on August 8, 2023 and the remaining 93.75% of the underlying shares vest in approximately equal quarterly installments thereafter for 15 quarters.

Issuer

GoodRx Holdings, Inc.

CIK 0001809519

Entity typeother

Related Parties

1
  • filerCIK 0001924892

Filing Metadata

Form type
4
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 5:14 PM ET
Size
8.3 KB